Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiglucerase in Chinese Patients With Type 3 Gaucher Disease
CTR20202132Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2020
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of imiglucerase in Gaucher disease type 3, sponsored by Sanofi. Started Nov 2020; status: completed.
02
Drugs
imiglucerase
03
Conditions
Gaucher disease type 3
Beyond the preview
Go deeper on CTR20202132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202132.